Macrolide antibiotics like azithromycin and clarithromycin can prolong the QT interval and trigger dangerous heart rhythms, especially in older adults or those on other medications. Understanding the real risks and knowing when to avoid them can save lives.
Azathioprine and mycophenolate are key immunosuppressants used after transplants and for autoimmune diseases. Learn how their interactions, dosing rules, and genetic risks affect safety and effectiveness - and what you need to ask your doctor.
Prescription discount programs can save you hundreds on generic drugs - but often don't help with brand-name medications. Learn how GoodRx, manufacturer coupons, and PAPs really work - and when they cost more than they save.
Non-opioid pain management offers safer, effective alternatives to opioids for chronic and acute pain. From physical therapy to new drugs like suzetrigine, proven options exist without the risk of addiction.
Biologics make up just 2% of prescriptions but half of drug spending. Biosimilars can save costs, but pharmacists play a key role in counseling patients and handling substitutions. Learn how they overcome barriers like patient hesitancy and prescriber resistance.
Tentative approval from the FDA means a generic drug meets all quality standards but can't launch yet due to patents or exclusivity. Common delays include review cycles, patent litigation, complex manufacturing, and market disincentives - leaving patients waiting for affordable options.
Methotrexate and NSAIDs can dangerously interact, raising methotrexate levels and risking kidney damage. Learn who's at risk, which NSAIDs are safest, and how to monitor your health to avoid life-threatening toxicity.
NAFLD and NASH are different stages of fatty liver disease. NASH involves inflammation and scarring, raising risk of cirrhosis and liver cancer. Lifestyle changes can reverse early damage - but late-stage fibrosis is harder to treat.